Darwinian medicine: What evolutionary medicine offers to endothelium researchers

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 122-128

  Nesse, Randolph M ^a   Weder, Alan B ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862564327     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.016     Document Type: Chapter

References (41)

1. Mayr E. The Growth of Biological Thought: Diversity, Evolution, and Inheritance. Cambridge: The Belknap Press of Harvard University Press, 1982.
2. Mayr E. What Makes Biology Unique?: Considerations on the Autonomy of a Scientific Discipline. New York: Cambridge University Press, 2004.
3. Tinbergen N. On aims and methods in ethology. Zeitschrift fur Tierpsychologie 1963; 20:410–433.
4. Stearns SC, Ebert D. Evolution in health and disease: a work in progress. Q Rev Biol. 2001; 76: 417.
5. Nesse RM, Williams GC. Evolution and the origins of disease. Sci Am. 1998; 279(5):86–93.
6. Nesse RM, Williams GC. Why We Get Sick. New York: Times Books, 1994.
7. Stearns S, ed. Evolution in Health and Disease. Oxford: Oxford University Press, 1998.
8. Williams GC, Nesse RM. The dawn of Darwinian medicine. Q Rev Biol. 1991; 66:1–22.
9. Neel JV, Julius S, Weder A, Yamada M, Kardia SL, Haviland MB. Syndrome X: is it for real? Gen Epidemiol. 1998; 15:19.
10. Eaton SB, Strassman BI, Nesse RM, et al. Evolutionary health promotion. Prev Med. 2002; 34(2):109–118.
11. Ewald P. Evolution of Infectious Disease. New York: Oxford University Press, 1994.
12. Williams GC. The Pony Fish's Glow: And Other Clues to Plan and Purpose in Nature. New York: BasicBooks, 1997.
13. Williams GC. Adaptation and Natural Selection: A Critique of Some Current Evolutionary Thought. Princeton NJ: Princeton University Press, 1966.
14. Dawkins R. The Selfish Gene. Oxford: Oxford University Press, 1976.
15. G. C. Williams. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957; 11:398–411.
16. Austad SN. Why We Age: What Science Is Discovering about the Body's Journey Throughout Life.New York: J.Wiley & Sons, 1997.
17. Kruger D, Nesse R. Sexual selection and the male:female mortality ratio. Evolutionary Psychology. 2004; 2:66–85.
18. Kruger DJ, Nesse RM. Anevolutionary life-history framework for understanding sex differences in human mortality rates. Human Nat. 2006; 17:74–97.
19. Nesse RM, Natural selection and the regulation of defenses: a signal detection analysis of the smoke detector principle. Evolution and Human Behavior. 2005; 26:88–105.
20. Cohen JC, Kiss RS, Persemlids A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 2004; 305:869–872.
21. Finch CE, Sapolsky RM. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol Aging. 1999; 20(4):407–428.
22. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med. 2002; 8:1211– 1217.
23. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med. 2000; 28 (12):1815–1826.
24. Ewald PW, Cochran GM. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment. J Infect Dis. 2000; 181(Suppl 3): S394–401.
25. Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997; 100: 2680–2690.
26. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol. 1993; 68:495–532.
27. Lippi G, Guidi G. Lipoprotein(a): from ancestral benefit to modern pathogen? QJM 2000; 93:75–84.
28. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Ohta Y, YasueH.LPCinoxidizedLDLelicits vasocontractionandinhibits endothelium-dependent relaxation. Am J Physiol. 1994; 267(6 Pt 2):H2441–H2449.
29. Lehrke M, Lazar MA. Inflamed about obesity. Nat Med. 2004; 10:126–127.
30. Eaton SB. Humans, lipids and evolution. Lipids. 1992; 27:814– 820.
31. Holvoet P, Kritchevsky SB, Tracy RP, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes. 2004; 53:1068– 1073.
32. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003; 108(24):2957– 2963.
33. Tobias P, Curtiss LK. Thematic review series:Theimmune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res. 2005; 46:404–411.
34. Cannon CP, Braunwald E, McCabe CH, et al.; Pravastatin or Atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med. 2005; 352(16):1646–1654.
35. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24:2227–2236.
36. Wu A, Hinds CJ, Thiemermann C. High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications. Shock. 2004; 21:210–221.
37. Jenkins DJ, Kendall CW, Marchie A, et al. The Garden of Eden – plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century. Comp Biochem Physiol A Mol Integr Physiol. 2003; 136:141–151.
38. Barker DJ. Fetal origins of cardiovascular disease. Ann Med. 1999; 31(Suppl 1):3–6.
39. Hales CN, Barker DJ. The thrifty phenotype hypothesis. BrMed Bull 2001; 60:5–20.
40. Roma P, Gregg RE, Meng MS, et al. In vivo metabolism of amutant formof apolipoprotein A-I, apo A-IMilano, associated with familial hypoalphalipoproteinemia. J Clin Invest. 1993; 91:1445– 1452.
41. Fox PL, Mazumder B, Ehrenwald E, Mukhopadhyay CK. Ceruloplasmin and cardiovascular disease. Free Radic BiolMed. 2000; 28:1735–1744.